GPR19 is a class A orphan-derived G protein-coupled receptor that links the secreted peptide adropin to MAPK/ERK1/2 signaling and to the regulation of organismal physiology spanning circadian timing, ingestive behavior, and whole-body metabolism (PMID:28476646, PMID:34789778). Adropin activation of GPR19 stimulates ERK1/2 phosphorylation and upregulates E-cadherin, driving a mesenchymal-to-epithelial transition and reducing invasion in breast cancer cells (PMID:28476646); in the rat hypothalamus GPR19 is required for adropin's suppression of water-deprivation-induced drinking (PMID:26739651). In the brain, GPR19 is enriched in the dorsal suprachiasmatic nucleus where its expression oscillates under control of a cAMP-responsive element, and its loss lengthens circadian period, blunts light-induced phase delays and c-Fos induction, and downregulates night-peaking clock genes including Bmal1 and Gpr176 (PMID:34789778). Systemic Gpr19 deletion raises energy expenditure in both sexes but produces male-specific glucose intolerance and diet-induced hepatomegaly with reduced hepatic fatty acid oxidation gene expression, defining a sex-dependent metabolic role (PMID:37061564).